Shopping Cart
Remove All
Your shopping cart is currently empty
(R)-CR8 trihydrochloride (CR8, (R)-Isomer trihydrochloride) is a CDK1/2/5/7/9 inhibitor that acts as a molecular glue degrader with neuroprotective activity and induces apoptosis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $35 | - | In Stock | |
| 5 mg | $56 | - | In Stock | |
| 10 mg | $85 | - | In Stock | |
| 25 mg | $155 | - | In Stock | |
| 50 mg | $233 | - | In Stock | |
| 100 mg | $328 | - | In Stock | |
| 200 mg | $489 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $67 | - | In Stock |
| Description | (R)-CR8 trihydrochloride (CR8, (R)-Isomer trihydrochloride) is a CDK1/2/5/7/9 inhibitor that acts as a molecular glue degrader with neuroprotective activity and induces apoptosis. |
| Targets&IC50 | CDK2-CyclinE:0.041 μM, CDK5-p25:0.11 μM, CDK7-CyclinH:1.1 μM, CDK2:0.072 μM, CK1δ/ε:0.4 μM, CDK9-CyclinT1:0.18 μM, CDK1:0.09 μM |
| In vitro | In the SH-SY5Y cell line, (R)-CR8 trihydrochloride (0.1, 1, 10, 100 μM; 24 hours) reduced cell survival in a dose-dependent manner[1]. |
| In vivo | In 10 to 12-week-old male Sprague-Dawley rats (310 to 330 g), administration of (R)-CR8 trihydrochloride at 5 mg/kg (i.p.) resulted in a significant reduction in lesion size[2]. |
| Synonyms | CR8, (R)-Isomer trihydrochloride |
| Molecular Weight | 540.92 |
| Formula | C24H32Cl3N7O |
| Cas No. | 1786438-30-9 |
| Smiles | Cl.Cl.Cl.CC[C@H](CO)Nc1nc(NCc2ccc(cc2)-c2ccccn2)c2ncn(C(C)C)c2n1 |
| Relative Density. | 1.31g/cm3 |
| Color | White |
| Appearance | Solid |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 30 mg/mL (55.46 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.7 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.